Selective Immunosuppressants (Imlifidasa IV.)
Status
Active
Submission Deadline
10 days remaining
Contracting authority
Institut klinické a experimentální medicíny19 more open tenders view
Location
Praha, Czechia
Estimated Value
CZK 102,500,000
Procedure
Open Procedure · Supplies
Category
Immunosuppressive agents.
Published
Reference
ted-530334-2026
Source
Delivery of Medicinal Products: Regular deliveries of medicinal products for parenteral administration, containing the active substance Imlifidasa (ATC group L04AA41), for the treatment of hospitalized patients in approved indications according to the Summary of Product Characteristics (SPC) valid on the date of bid submission.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 530334-2026HTML
- TED PDF — 530334-2026PDF
- TED XML — 530334-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
EU Funded
Yes
Electronic Submission
Required
Legal Basis
32014L0024